438050-53-4 Usage
Uses
Used in Medicinal Chemistry:
(3R,5S)-rel-4-(Chlorocarbonyl)-3,5-dimethyl-1-piperazinecarboxylic acid tert-butyl ester is used as a synthetic intermediate for the development of novel pharmaceuticals. Its unique structural features, including the chlorocarbonyl group and the piperazine ring, make it a valuable component in the design of bioactive molecules with potential therapeutic applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (3R,5S)-rel-4-(Chlorocarbonyl)-3,5-dimethyl-1-piperazinecarboxylic acid tert-butyl ester serves as a key building block in the synthesis of drug candidates. Its presence in molecular structures can contribute to the modulation of biological targets, potentially leading to the discovery of new treatments for various diseases and conditions.
Used in Drug Discovery:
(3R,5S)-rel-4-(Chlorocarbonyl)-3,5-dimethyl-1-piperazinecarboxylic acid tert-butyl ester is utilized in drug discovery processes to explore its potential as a precursor to compounds with specific pharmacological properties. The chlorine atom and the piperazine ring within the molecule offer opportunities for further chemical modifications, enhancing its applicability in creating diverse drug-like molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 438050-53-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,8,0,5 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 438050-53:
(8*4)+(7*3)+(6*8)+(5*0)+(4*5)+(3*0)+(2*5)+(1*3)=134
134 % 10 = 4
So 438050-53-4 is a valid CAS Registry Number.
438050-53-4Relevant academic research and scientific papers
MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE
-
Page/Page column 156; 194-195, (2021/08/13)
The present invention relates to compounds of Formula (Ia), pharmaceutically acceptable salts of compounds of Formula (Ia), and pharmaceutical compositions thereof that modulate the activity of the muscarinic acetylcholine receptor M4. Compounds, pharmaceutical salts of compounds, and pharmaceutical compositions of the present invention are directed to methods useful in the treatment or prophylaxis of a neurological disease, disorder, or symptom, and conditions related thereto.
